FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
+7.49%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$303M
AUM Growth
+$303M
(+10%)
Cap. Flow
+$40.4M
Cap. Flow
% of AUM
13.32%
Top 10 Holdings %
Top 10 Hldgs %
76.75%
Holding
21
New
1
Increased
7
Reduced
2
Closed
1
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$14.4M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$9.1M |
| 3 |
Keros Therapeutics
KROS
|
$8.4M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.67M |
| 5 |
argenx
ARGX
|
$7M |
Top Sells
| 1 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$15.6M |
| 2 |
ALLK
Allakos
ALLK
|
$276K |
| 3 |
AMRN
Amarin Corp
AMRN
|
$33.7K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
1
DELISTED
Zogenix, Inc.
ZGNX
| $40.7M | 13.41% | 2,502,259 +560,000 | +29% | +$9.1M |
|
2
Insmed
INSM
$28.8B
| $35.8M | 11.8% | 1,313,607 | – | – |
|
3
Enanta Pharmaceuticals
ENTA
$180M
| $29M | 9.55% | 387,400 +70,448 | +22% | +$5.27M |
|
|
4
argenx
ARGX
$43.6B
| $27.5M | 9.08% | 78,644 +20,000 | +34% | +$7M |
|
|
GBT
5
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $21.7M | 7.17% | 743,000 +493,000 | +197% | +$14.4M |
|
6
Viridian Therapeutics
VRDN
$1.5B
| $18.7M | 6.15% | 944,092 | – | – |
|
7
Nuvalent
NUVL
$5.52B
| $17.4M | 5.74% | 914,614 | – | – |
|
|
8
Keros Therapeutics
KROS
$618M
| $17.1M | 5.65% | 292,833 +143,500 | +96% | +$8.4M |
|
9
Cogent Biosciences
COGT
$1.69B
| $13.4M | 4.41% | 1,558,975 | – | – |
|
10
Instil Bio
TIL
$182M
| $11.5M | 3.8% | 673,905 | – | – |
|
11
Acadia Pharmaceuticals
ACAD
$4.38B
| $9.73M | 3.21% | 416,817 | – | – |
|
12
Tyra Biosciences
TYRA
$675M
| $9.08M | 2.99% | 645,349 +146,309 | +29% | +$2.06M |
|
|
PNT
13
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $8.51M | 2.81% | 1,519,382 +419,893 | +38% | +$2.35M |
|
|
AMRN
14
Amarin Corp
AMRN
$311M
| $8.42M | 2.78% | 2,498,237 -10,000 | -0.4% | -$33.7K |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.67M | 2.53% | +55,647 | New | +$7.67M |
|
16
Iovance Biotherapeutics
IOVA
$807M
| $7.44M | 2.45% | 389,588 | – | – |
|
17
Axsome Therapeutics
AXSM
$6.05B
| $7.09M | 2.34% | 187,598 | – | – |
|
|
VRNA
18
Verona Pharma
VRNA
$9.16B
| $6.23M | 2.05% | 926,602 | – | – |
|
19
Astria Therapeutics
ATXS
$349M
| $4.91M | 1.62% | 911,736 | – | – |
|
|
ALLK
20
DELISTED
Allakos
ALLK
| $1.44M | 0.48% | 147,189 -28,173 | -16% | -$276K |
|
|
TRIL
21
DELISTED
Trillium Therapeutics Inc.
TRIL
| – | – | -886,281 | Closed | -$15.6M |
|